Literature DB >> 2692364

Plication of the sapheno-femoral junction. An alternative to ligation?

G V Belcaro1.   

Abstract

Plication of the long saphenous vein at the sapheno-femoral junction (SFJ) is an interesting alternative to flush ligation and stripping in superficial venous incompetence. This technique abolishes venous reflux at the SFJ without altering the vein which may be useful for peripheral arterial surgery or coronary artery bypass grafting. The selection of the ideal candidate for plication must be done by ambulatory venous pressure measurements, Doppler and duplex scanning which indicate and quantify the superficial vein incompetence. The plication of the SFJ reduces the calibre of the vein to 60%-70% of its calibre for a length of 1.5 cm allowing the valve cusps to close when flow in the femoral vein is reversed (i.e. by Valsalva manoeuvre). In this series of ten patients, evaluated 6 months after plication of the SFJ, venous reflux was significantly reduced (at Doppler and duplex examination and ambulatory venous pressure measurements) and the improvement of haemodynamic data was associated with improvement of symptoms. In conclusion, considering these data, SFJ plication is an effective physiological alternative to flush ligation but long term results must be evaluated before using it for the treatment of incompetence of the long saphenous vein.

Entities:  

Mesh:

Year:  1989        PMID: 2692364

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  2 in total

1.  External banding valvuloplasty for incompetence of the great saphenous vein: 10-year results.

Authors:  Jin-Hyun Joh; Kyung-Bok Lee; Woo-Sung Yun; Byung-Boong Lee; Young-Wook Kim; Dong-Ik Kim
Journal:  Int J Angiol       Date:  2009

2.  Long-term results of external valvuloplasty in adult patients with isolated great saphenous vein insufficiency.

Authors:  Atilla Sarac; Artan Jahollari; Sureyya Talay; Sevket Ozkaya; Ertugrul Ozal
Journal:  Clin Interv Aging       Date:  2014-04-05       Impact factor: 4.458

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.